Medscape5d
Intravenous Immunoglobulin Likely More Effective Than Corticosteroids in Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...
Soleo Health Unveils Ambulatory Infusion Suite in Denver
The Soleo Health Denver AIS, located at 9250 East Costilla Avenue, Suite 440, Greenwood Village, CO 80112, 303.968.1915, is ...
Johnson & Johnson: Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis
Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...
Yahoo Finance6d
Dianthus Therapeutics, Inc. (DNTH)
Initiation of a single, two-part, pivotal Phase 3 trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) anticipated by YE’24 Phase 2 MaGic trial of DNTH103 in generalized ...
Immunoglobulin Market: Intravenous Immunoglobulin (IVIG) Remains The Most Widely Used Method Due To Its Effectiveness
PORTLAND, OR, UNITED STATES, January 6, 2025 /EINPresswire / -- The global immunoglobulin market is experiencing significant growth, driven by the increasing prevalence of immune-related diseases and ...
Immunovant (NASDAQ:IMVT) Shares Gap Down – Here’s What Happened
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $25.19, but opened at $24.52. Immunovant shares last traded ...
pharmaphorum6d
FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...
argenx (NASDAQ:ARGX) Given New $725.00 Price Target at Piper Sandler
(NASDAQ:ARGX – Free Report) had its price target lifted by Piper Sandler from $620.00 to $725.00 in a research report report published on Tuesday morning,Benzinga reports. The brokerage currently has ...
HME News1d
Soleo Health opens suite in Denver
Soleo Health has opened a new ambulatory infusion suite in the metro Denver area to complement its existing home infusion service offerings.
Le Lézard2h
Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis
Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...
Halozyme: 'Accidental' Business Model Has Exciting Upside Opportunities In 2025
Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...
The Hill6d
JetBlue fined $2 million for chronic flight delays
The DOT said it is currently investigating other airlines for unrealistic flight schedules that cause chronic delays. “Illegal chronic flight delays make flying unreliable for travelers.